EC Number   |
Title |
Organism |
|---|
   1.14.14.55 | Enzyme kinetics for the formation of 3-hydroxyquinine and three new metabolites of quinine in vitro; 3-hydroxylation by CYP3A4 is indeed the major metabolic pathway |
Homo sapiens |
| 1.14.14.55 | Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine |
Homo sapiens |
| 1.14.14.55 | Influence of a Nigerian honey on CYP3A4 biotransformation of quinine in healthy volunteers |
Homo sapiens |
| 1.14.14.55 | Is quinine a suitable probe to assess the hepatic drug-metabolizing enzyme CYP3A4? |
Homo sapiens |
| 1.14.14.55 | Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes |
Homo sapiens |
| 1.14.14.55 | Ontogeny of hepatic microsomal 3-hydroxylation of quinine in Adelie Penguins |
Pygoscelis adeliae |
| 1.14.14.55 | Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man |
Homo sapiens |
| 1.14.14.55 | The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo |
Homo sapiens |
| 1.14.14.55 | 4Beta-hydroxycholesterol is a new endogenous CYP3A marker: relationship to CYP3A5 genotype, quinine 3-hydroxylation and sex in Koreans, Swedes and Tanzanians |
Homo sapiens |
| 1.14.14.55 | CYP3A5 genotype has significant effect on quinine 3-hydroxylation in Tanzanians, who have lower total CYP3A activity than a Swedish population |
Homo sapiens |
